MS: Pharmaceutical Sciences with Specialization in Drug Development, University of Cincinnati, College of Pharmacy, Cincinnati, OH, 2010,
PhD: Molecular and Developmental Biology, University of Cincinnati, College of Medicine, Cincinnati, OH, 2003,
BS: Biology, John Carroll University, University Heights, OH, 1998,
Post-doctoral Research Fellow: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2008,
Regulations, management, and coordination of clinical research trials in rare lung diseases, specifically pulmonary alveolar proteinosis (PAP); pathogenesis of PAP; developing and validating clinical research tests to diagnose PAP; evaluating several therapeutic options for individuals with PAP; translational pulmonary science; rare lung disease clinical research diagnostic testing; diagnosis of individuals with hereditary or autoimmune PAP clinical trials; National PAP Registry; inhaled GM-CSF treatment for individuals with autoimmune PAP and hereditary PAP; safety and efficacy of Pioglitazone for autoimmune PAP patients
DEVELOPMENT OF A DRIED SERUM ASSAY FOR THE DETECTION OF GM-CSF ANTIBODIES TO AID IN THE DIAGNOSIS OF AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS (APAP) Chest. 2025; 168(4):a3757.
Pharmacokinetics and pharmacodynamics of inhaled molgramostim in healthy people. BMJ Open Respiratory Research. 2025; 12(1).
Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis. New England Journal of Medicine. 2025; 393(8):764-773.
Autoimmune Pulmonary Alveolar Proteinosis: Update from the US National PAP Registry. American Journal of Respiratory and Critical Care Medicine. 2025; 211(Supplement_1):a1814-a1814.
Pulmonary hypertension during high-dose GM-CSF therapy of autoimmune pulmonary alveolar proteinosis. Pulmonary Circulation. 2024; 14(4):e70020.
A toxicology study of Csf2ra complementation and pulmonary macrophage transplantation therapy of hereditary PAP in mice. Molecular Therapy: Methods & Clinical Development. 2024; 32(2):101213.
Disseminated nocardiosis and anti-GM-CSF antibodies. European Journal of Clinical Microbiology and Infectious Diseases. 2024; 43(5):1003-1007.
Human inherited CCR2 deficiency underlies progressive polycystic lung disease. Cell. 2024; 187(2):390-408.e23.
Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients. European Respiratory Journal. 2024; 63(1).
A dried blood spot test for diagnosis of autoimmune pulmonary alveolar proteinosis. Journal of Immunological Methods. 2022; 511:113366.